This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A second look: Discussing the potential role of Amylyx' Avexitide in post bariatric hypoglycemia (PBH)
Ticker(s): AMLXWho's the expert?
Institution: Stanford
- Served as Instructor of Medicine (Endocrinology) at Stanford,
- Dr. Craig’s research interests center on examining the roles of incretin gut hormones on glucose metabolism and weight, and on the development and application of incretin-based therapies for treatment of related conditions. Clinical research has focused on elucidating the role of GLP-1 in mediating hyperinsulinemic hypoglycemia conditions, including post-bariatric hypoglycemia (PBH) and congenital hyperinsulinism (HI), and on the role of GLP-1 in influencing feeding behaviors.
- Accomplished biopharma executive. Directly supported development of various investigational drugs, including peptide injectables and oral small molecules spanning rare and common metabolic and neuro/neuro-endocrine disorders
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
